Regeneron (REGN) Stock Price & AI Analysis

$9.97 (0.97%)

Regeneron | Analysts Recommandations

No Ratings

Regeneron | Latest news

Market Data


Technical Indicators

Company Profile

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.